James Hardie Selling European Fermacell Business for $980 Million to Holcim
James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.
How this was made

The 30-second read
Why it matters
The deal will materially affect both companies' balance sheets and strategic positioning.
Market read
A $980M cross‑border M&A that could reshape the European construction materials landscape.
What to watch
Potential regulatory scrutiny in Europe and currency risk on the EUR‑denominated cash.
Background
James Hardie is refocusing on higher‑growth markets, while Holcim seeks to broaden its product range in Europe.
Ticker impact
James Hardie announced the sale of its European Fermacell business to Holcim for $980 million.
Potential upside as debt reduction and buyback signal improve valuation.
Large cash inflow and clear debt‑paydown plan are material catalysts.
Market effects
Strengthens construction materials sector outlook by consolidating European cement assets.
European building‑materials market may see tighter competition as Holcim expands.
Large M&A in a core industrial sector draws attention from global investors.
Counterpoint
The purchase price may be high; integration costs could outweigh benefits, pressuring Holcim's margins.
Key entities
- CompanyJames Hardie Industries
Seller of the European Fermacell business.
- CompanyHolcim
Buyer of the European Fermacell business.
